BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Update

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 1,200 shares, a growth of 20.0% from the March 15th total of 1,000 shares. Based on an average daily trading volume, of 10,000 shares, the short-interest ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are sold short.

BioNxt Solutions Stock Performance

Shares of OTCMKTS:BNXTF opened at $0.30 on Wednesday. BioNxt Solutions has a 52-week low of $0.11 and a 52-week high of $0.43. The business’s 50 day simple moving average is $0.36 and its two-hundred day simple moving average is $0.27. The firm has a market cap of $34.93 million, a P/E ratio of -7.54 and a beta of 0.56.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.